Skip to content

Public FDA record

Z-1608-2024: NexGen CR-Flex Femoral Component, Size E and Size E Minus (E-). Component of the NexGen CR-Flex Porous Fe

Recall record Z-1608-2024 for Zimmer, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1608-2024
Company in FDA record
Zimmer, Inc.
FDA classification date
Apr 22, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Out of specification violation of devices that results in a gap existing within the fixture that presses the fiber metal pad to the substrate, causing the pad to not fully bond to the substrate.

Source facts

Action
Consignees were sent an URGENT MEDICAL DEVICE RECALL notification dated 3/28/24. Distributors are to review the provided notification, notify the appropriate team members of the contents of the notification, locate and quarantine affected product in your inventory, return all affected product from the respective distributorship and affected hospitals to Zimmer by submitting an Inventory Return Certification Form to CorporateQuality.PostMarket@zimmerbiomet.com (international returns are to be coordinated by emailing zimmerbiometintlirarequests@zimmerbiomet.com), and retain a copy of the Inventory Return Certification and product returns forms. Risk Managers are to review the provided notification, notify the appropriate team members of the contents of the notification, locate and quarantine affected product in your inventory with the assistance of a Zimmer Biomet sales representative, the Zimmer Biomet sales representative will remove affected devices from consignee facilities, return the provided Certificate of Acknowledgement to CorporateQuality.PostMarket@zimmerbiomet.com, and retain a copy of the acknowledgement form for your records. Surgeons are to review the provided notification, complete the provided Certificate of Acknowledgement to CorporateQuality.PostMarket@zimmerbiomet.com, retain a copy of the acknowledgement form for your records; there is no specific patient monitoring instructions related to this recall. Consignees with any questions are to contact Customer Service at 574-371-3071 from Monday through Friday between the hours of 8:00 am and 5:00 pm EST.
Initiated
2024-03-28
Root cause
Process change control
Distribution
Worldwide distribution - US Nationwide including the states of AK, AL, CA, FL, GA, IL, IN, KS, KY, MA, MD, ME, MI, MN, MO, NC, NH, NJ, NM, NY, OH, OK, OR, PA, SC, TN, TX, VA, WA, WI and the countries of Australia, Canada, Japan, Netherlands.
Recall number
Z-1608-2024
Recall status
Open, Classified
CDRH record ID
206937
FDA classified
2024-04-22
Recall event number
94327

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗